Behavioural Brain Research, 352, 161171
transient impairment of glucose tolerance is possible, particularly in individuals with pre-existing insulin resistance Injection site reactions: Mild and typically localised Contraindications include active malignancy (GH-IGF-1 signalling can promote tumour growth), pituitary-dependent conditions, pregnancy, and active diabetic retinopathy
Adems, los arGLP-1 son agentes antihiperglucemiantes ms potentes comparados con los iSGLT2s en la poblacin con ERD, y algunos tambin confieren un mayor potencial de prdida de peso, como semaglutida
and supporting the gut microbiome
La mayor incidencia que aparece en los recin nacidos de peso ms bajo podra estar relacionada con una mayor inmadurez heptica, una disminucin en la sntesis de cidos biliares y una menor efectividad de la circulacin enteroheptica
What Makes You Not A Candidate For GLP-1